By REUTERS
NYT Europe
The cost of insulin for treating type 1 diabetes in the United States nearly doubled over a five-year period, underscoring a national outcry over rising drug prices, according to a new analysis shared with Reuters.
Published date: January 22, 2019 at 01:22PM
Reuters
New York Times article
Няма коментари:
Публикуване на коментар